{
    "xml": "<topic id=\"PHP3872\" outputclass=\"drug\" rev=\"1.13\" type=\"drug\" namespace=\"/drugs/entecavir\" basename=\"entecavir\" title=\"ENTECAVIR\">\n<title>ENTECAVIR</title>\n<body>\n<data name=\"vtmid\">416248007</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\n</body>\n<topic id=\"PHP52115\" outputclass=\"indicationsAndDose\" rev=\"1.17\" parent=\"/drugs/entecavir\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Chronic hepatitis B in patients with compensated liver disease (with evidence of viral replication, and histologically documented active liver inflammation or fibrosis) not previously treated with nucleoside analogues</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>500&#8239;micrograms once daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Chronic hepatitis B in patients with compensated liver disease (with evidence of viral replication, and histologically documented active liver inflammation or fibrosis) and lamivudine-resistance</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>1&#8239;mg once daily, consider other treatment if inadequate response after 6 months.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Chronic hepatitis B in patients with decompensated liver disease</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>1&#8239;mg once daily.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP52230\" outputclass=\"cautions\" rev=\"1.13\" parent=\"/drugs/entecavir\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">HIV infection&#8212;risk of HIV resistance in patients not receiving &#8216;highly active antiretroviral therapy&#8217;</ph>; <ph outputclass=\"caution\">lamivudine-resistant chronic hepatitis B&#8212;risk of entecavir resistance</ph>\n</p>\n</section>\n<section outputclass=\"importantAdvice\">\n<title>Cautions, further information</title>\n<sectiondiv>\n<p>Discontinue if deterioration in liver function, hepatic steatosis, progressive hepatomegaly or unexplained lactic acidosis.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP51965\" outputclass=\"sideEffects\" rev=\"1.11\" parent=\"/drugs/entecavir\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Diarrhoea</ph>; <ph outputclass=\"sideEffect\">dizziness</ph>; <ph outputclass=\"sideEffect\">dyspepsia</ph>; <ph outputclass=\"sideEffect\">fatigue</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">raised serum amylase</ph>; <ph outputclass=\"sideEffect\">raised serum lipase</ph>; <ph outputclass=\"sideEffect\">sleep disturbances</ph>; <ph outputclass=\"sideEffect\">vomiting</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"uncommon\">\n<p outputclass=\"title\">Uncommon</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Alopecia</ph>; <ph outputclass=\"sideEffect\">rash</ph>; <ph outputclass=\"sideEffect\">thrombocytopenia</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP52226\" outputclass=\"conceptionAndContraception\" parent=\"/drugs/entecavir\">\n<title>Conception and contraception</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Effective contraception required during treatment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP52070\" outputclass=\"pregnancy\" parent=\"/drugs/entecavir\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Toxicity in <i>animal</i> studies&#8212;manufacturer advises use only if potential benefit outweighs risk.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP52240\" outputclass=\"breastFeeding\" parent=\"/drugs/entecavir\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises avoid&#8212;present in milk in <i>animal</i> studies.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP52002\" outputclass=\"renalImpairment\" parent=\"/drugs/entecavir\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p>Reduce dose if eGFR less than 50&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Consult product literature.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP51887\" outputclass=\"monitoringRequirements\" parent=\"/drugs/entecavir\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p>Monitor liver function tests every 3 months, and viral markers for hepatitis B every 3&#8211;6 months during treatment (continue monitoring for at least 1 year after discontinuation&#8212;recurrent hepatitis may occur on discontinuation).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP52254\" outputclass=\"directionsForAdministration\" rev=\"1.10\" parent=\"/drugs/entecavir\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p>To be taken at least 2 hours before or 2 hours after food.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP58709\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.8\" parent=\"/drugs/entecavir\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p>Flavours of oral liquid formulations may include orange.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP52028\" outputclass=\"patientAndCarerAdvice\" rev=\"1.16\" parent=\"/drugs/entecavir\">\n<title>Patient and carer advice</title>\n<body>\n<section outputclass=\"generalPatientAdvice\">\n<sectiondiv>\n<p>Patients or carers should be counselled on the administration of entecavir tablets and oral solution.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP51852\" outputclass=\"nationalFunding\" rev=\"1.16\" parent=\"/drugs/entecavir\">\n<title>National funding/access decisions</title>\n<body>\r\n<section>\r\n<sectiondiv outputclass=\"niceTechnologyAppraisals\">\r\n<p outputclass=\"title\">NICE technology appraisals (TAs)</p>\r\n<sectiondiv outputclass=\"niceTechnologyAppraisal\">\r\n<p outputclass=\"fundingIdentifier\">NICE TA153</p>\r\n<sectiondiv>\r\n<p outputclass=\"title\">Entecavir for chronic hepatitis B (August 2008)</p>\r\n<p>Entecavir is an option for the treatment of chronic hepatitis B.</p>\n</sectiondiv>\n<xref format=\"html\" href=\"http://www.nice.org.uk/TA153\">www.nice.org.uk/TA153</xref>\n</sectiondiv>\n</sectiondiv>\r\n </section>\r\n\r\n</body>\n</topic>\n<topic id=\"PHP3872-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/entecavir\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76665\" title=\"Tablet\" namespace=\"/drugs/entecavir/tablet\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76672\" title=\"Oral solution\" namespace=\"/drugs/entecavir/oral-solution\">Oral solution</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78240\" namespace=\"/treatment-summaries/hepatitis\" title=\"Hepatitis\" count=\"4\" rel=\"backlink\">Hepatitis</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76665\" namespace=\"/drugs/entecavir/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76672\" namespace=\"/drugs/entecavir/oral-solution\" title=\"Oral solution\" count=\"1\" rel=\"link\">Oral solution</xref>\n</links>\n</topic>",
    "id": "PHP3872",
    "outputclass": "drug",
    "rev": "1.13",
    "type": "drug",
    "namespace": "/drugs/entecavir",
    "basename": "entecavir",
    "title": "ENTECAVIR",
    "vtmid": "416248007",
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Chronic hepatitis B in patients with compensated liver disease (with evidence of viral replication, and histologically documented active liver inflammation or fibrosis) not previously treated with nucleoside analogues",
                        "html": "Chronic hepatitis B in patients with compensated liver disease (with evidence of viral replication, and histologically documented active liver inflammation or fibrosis) not previously treated with nucleoside analogues"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "500 micrograms once daily.",
                        "html": "<p>500&#8239;micrograms once daily.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Chronic hepatitis B in patients with compensated liver disease (with evidence of viral replication, and histologically documented active liver inflammation or fibrosis) and lamivudine-resistance",
                        "html": "Chronic hepatitis B in patients with compensated liver disease (with evidence of viral replication, and histologically documented active liver inflammation or fibrosis) and lamivudine-resistance"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "1 mg once daily, consider other treatment if inadequate response after 6 months.",
                        "html": "<p>1&#8239;mg once daily, consider other treatment if inadequate response after 6 months.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Chronic hepatitis B in patients with decompensated liver disease",
                        "html": "Chronic hepatitis B in patients with decompensated liver disease"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "1 mg once daily.",
                        "html": "<p>1&#8239;mg once daily.</p>"
                    }
                ]
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "HIV infection&#8212;risk of HIV resistance in patients not receiving &#8216;highly active antiretroviral therapy&#8217;",
                "html": "HIV infection&#8212;risk of HIV resistance in patients not receiving &#8216;highly active antiretroviral therapy&#8217;"
            },
            {
                "type": "cautions",
                "textContent": "lamivudine-resistant chronic hepatitis B&#8212;risk of entecavir resistance",
                "html": "lamivudine-resistant chronic hepatitis B&#8212;risk of entecavir resistance"
            }
        ],
        "importantAdvice": [
            {
                "type": "importantAdvice",
                "textContent": "Discontinue if deterioration in liver function, hepatic steatosis, progressive hepatomegaly or unexplained lactic acidosis.",
                "html": "<p>Discontinue if deterioration in liver function, hepatic steatosis, progressive hepatomegaly or unexplained lactic acidosis.</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Diarrhoea",
                        "html": "Diarrhoea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "dizziness",
                        "html": "dizziness",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "dyspepsia",
                        "html": "dyspepsia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "fatigue",
                        "html": "fatigue",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "raised serum amylase",
                        "html": "raised serum amylase",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "raised serum lipase",
                        "html": "raised serum lipase",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "sleep disturbances",
                        "html": "sleep disturbances",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "vomiting",
                        "html": "vomiting",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "uncommon": [
                    {
                        "type": "uncommon",
                        "textContent": "Alopecia",
                        "html": "Alopecia",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "rash",
                        "html": "rash",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "thrombocytopenia",
                        "html": "thrombocytopenia",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    }
                ]
            }
        }
    },
    "conceptionAndContraception": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Effective contraception required during treatment.",
                "html": "<p>Effective contraception required during treatment.</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Toxicity in animal studies&#8212;manufacturer advises use only if potential benefit outweighs risk.",
                "html": "<p>Toxicity in <i>animal</i> studies&#8212;manufacturer advises use only if potential benefit outweighs risk.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises avoid&#8212;present in milk in animal studies.",
                "html": "<p>Manufacturer advises avoid&#8212;present in milk in <i>animal</i> studies.</p>"
            }
        ]
    },
    "renalImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "textContent": "Reduce dose if eGFR less than 50 mL/minute/1.73 m2.",
                "html": "<p>Reduce dose if eGFR less than 50&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>"
            }
        ],
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Consult product literature.",
                "html": "<p>Consult product literature.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientParameters": [
            {
                "type": "patientParameters",
                "textContent": "Monitor liver function tests every 3 months, and viral markers for hepatitis B every 3&#8211;6 months during treatment (continue monitoring for at least 1 year after discontinuation&#8212;recurrent hepatitis may occur on discontinuation).",
                "html": "<p>Monitor liver function tests every 3 months, and viral markers for hepatitis B every 3&#8211;6 months during treatment (continue monitoring for at least 1 year after discontinuation&#8212;recurrent hepatitis may occur on discontinuation).</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "textContent": "To be taken at least 2 hours before or 2 hours after food.",
                "html": "<p>To be taken at least 2 hours before or 2 hours after food.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "textContent": "Flavours of oral liquid formulations may include orange.",
                "html": "<p>Flavours of oral liquid formulations may include orange.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "generalPatientAdvice": [
            {
                "type": "generalPatientAdvice",
                "textContent": "Patients or carers should be counselled on the administration of entecavir tablets and oral solution.",
                "html": "<p>Patients or carers should be counselled on the administration of entecavir tablets and oral solution.</p>"
            }
        ]
    },
    "nationalFunding": {
        "niceTechnologyAppraisals": [
            {
                "type": "niceTechnologyAppraisals",
                "references": [
                    {
                        "id": "http://www.nice.org.uk/TA153",
                        "label": "www.nice.org.uk/TA153"
                    }
                ],
                "fundingIdentifier": "NICE TA153",
                "textContent": "Entecavir for chronic hepatitis B (August 2008) Entecavir is an option for the treatment of chronic hepatitis B.\n\nwww.nice.org.uk/TA153",
                "html": "<p outputclass=\"title\">Entecavir for chronic hepatitis B (August 2008)</p> <p>Entecavir is an option for the treatment of chronic hepatitis B.</p><xref format=\"html\" href=\"http://www.nice.org.uk/TA153\">www.nice.org.uk/TA153</xref>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP76665",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76672",
                "label": "Oral solution",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "treatmentSummary": [
            {
                "id": "PHP78240",
                "label": "Hepatitis",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP76665",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76672",
                "label": "Oral solution",
                "type": "medicinalForm"
            }
        ]
    }
}